• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    J&J`s tuberculosis Sirturo lands full US, EU approvals

    08 Jul 2024 //

    FIERCE PHARMA

    NPPA invokes Para 3 of DPCO to direct Macleods to supply anti-TB drug to CMSS

    15 Jun 2024 //

    PHARMABIZ

    Enforcement Report - Week of April 17, 2024

    17 Apr 2024 //

    FDA

    Lupin, Glenmark recall drugs in US market: USFDA

    10 Apr 2024 //

    MONEYCONTROL

    Enforcement Report - Week of February 7, 2024

    07 Feb 2024 //

    FDA

    Fighting tuberculosis: EUROAPI’s rifampicin API meets new requirements for nitrosamine impurity standards

    24 Oct 2023 //

    PRESS RELEASE

    Enforcement Report - Week of June 7, 2023

    07 Jun 2023 //

    FDA

    Enforcement Report - Week of January 25, 2023

    25 Jan 2023 //

    FDA

    Enforcement Report - Week of January 18, 2023

    18 Jan 2023 //

    FDA

    Enforcement Report - Week of October 26, 2022

    26 Oct 2022 //

    FDA

    Enforcement Report - Week of October 5, 2022

    05 Oct 2022 //

    FDA

    Enforcement Report - Week of August 24, 2022

    24 Aug 2022 //

    FDA

    Stopping dementia at the nose with combination of rifampicin and resveratrol

    30 Dec 2021 //

    SCIENCEDAILY

    FDA addresses nitrosamines in TB drugs

    27 Aug 2020 //

    RAPS

    FDA works to mitigate shortages of rifampin and rifapentine after manufacturerE

    26 Aug 2020 //

    FDA

    Health Canada Issues Recalls of Bausch Health, Canada`s Rifampin

    17 Mar 2020 //

    HEALTH CANADA

    Class 4 Medicines Defect Information: Rifadin (rifampicin) 150mg Capsules

    17 Oct 2019 //

    MHRA

    Evotec receives $ 23.8 m grant to join the global fight against tuberculosis

    10 Jun 2019 //

    PRESS RELEASE

    FDA advisory panel recommends approval of TB Alliance`s tuberculosis treatment

    08 Jun 2019 //

    REUTERS

    WHO announces landmark changes in MDR-TB treatment regimens

    20 Aug 2018 //

    ECONOMIC TIMES

    New tuberculosis drug could help eradicate global killer

    02 Aug 2018 //

    PHARMAPHORUM

    Hikma Pharm`s Generic Rifampin approved in US as an antibiotic

    03 Mar 2016 //

    FDA

    ViiV Healthcare Announces PhII Study Results for First Two Drug

    23 Feb 2016 //

    PR NEWSWIRE

    Cholesterol,TB Drugs Recalled in Philippines Due to Failed Dissolution Tests

    08 Oct 2015 //

    NEWS INFERNO

    Drug Regulator Fixes Prices of 30 Formulation Packs

    08 May 2015 //

    NDTV

    Antibiotics Made By Emcure Pharmaceuticals Recalled In US

    28 Mar 2015 //

    THE ECONOMIC TIMES

    Heritage Pharmaceuticals, Inc., Ongoing Class II recall of RIFAMPIN for Injection,USP, 600 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724 NDC 23155-340-31 because of Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

    25 Mar 2015 //

    FDA

    HIV New Compound May Treat HIV, Drug-Resistant TB

    25 Feb 2015 //

    THE FINANCIAL EXPRESS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.